Iberdomide, a cereblon modulator promoting degradation of the transcription factors Ikaros and Aiolos, which affect leukocyte development and autoimmunity, is being evaluated for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results